Why the study?
Does the use of drug-eluting stents compared to bare-metal stents affect major adverse cardiovascular and cerebrovascular events or bleeding in patients on long-term warfarin treatment?
Does the use of drug-eluting stents compared to bare-metal stents affect major adverse cardiovascular and cerebrovascular events or bleeding in patients on long-term warfarin treatment?
In patients on long-term warfarin, drug-eluting stents with short triple therapy showed similar long-term rates of MACCE and major bleeding compared to bare-metal stents.
Answers are grounded in this paper and cite their sources.
Comparable MACCE rates with DES versus BMS in warfarin patients should not yet change practice; leaves open need for randomized confirmation.
BACKGROUND: The safety of drug-eluting stents (DES) in patients on long-term warfarin treatment has been questioned due to high risk of bleeding complications during prolonged triple (aspirin, clopidogrel, and warfarin) antithrombotic therapy. METHODS: We analysed the long-term outcome of 415 consecutive warfarin-treated patients who underwent DES (n = 191) or bare-metal (n = 224) stenting in six hospitals. RESULTS: The mean duration of triple therapy was longer (4.2 ± 3.1 versus 2.1 ± 1.8 months; P < 0.001) in the DES group. The incidence of major adverse cardiovascular and cerebrovascular events was comparable in the DES and bare-metal groups (39.8% versus 42.4%; P = 0.59) during a median follow-up of 3.5 years. Similarly, major bleeding events occurred equally often in both study groups (14.7% versus 12.9%). Six patients in the DES group and seven patients in the bare-metal group suffered stent thrombosis (3.1% versus 3.1%). In the propensity score analyses of 101 matched pairs, the outcome was similar in the two groups. CONCLUSION: Selective use of DES with a short triple therapy seems to be safe in patients with warfarin therapy. The prognosis of this fragile patient population is quite poor, and major bleeding events are common irrespective of stent type.
No takes yet. Share an insight, caveat, or question.
Annala et al. (2011) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: